Cyclerion Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $1,025 | $875 |
Gross Profit | -730 | 1,025 | 875 | |
EBITDA | -1,755 | -3,177 | -799 | -976 |
Net Income | -1,755 | -3,177 | -799 | -976 |
Net Change In Cash | 0 | 0 | 1,025 | 875 |
Free Cash Flow | -1,366 | -1,242 | -1,579 | -264 |
Cash | 1,391 | 2,823 | 3,240 | 4,568 |
Basic Shares | 4,251 | 4,205 | 3,225 | 3,225 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $2,074 | $2,000 | $0 | $297 |
Gross Profit | 2,074 | 2,000 | -1,315 | -5,282 |
EBITDA | -3,528 | -3,057 | -9,582 | -18,181 |
EBIT | -3,628 | -9,647 | -18,246 | |
Net Income | -3,528 | -3,057 | -5,263 | -44,078 |
Net Change In Cash | 2,074 | 2,000 | 0 | 297 |
Free Cash Flow | -3,314 | -4,333 | -21,245 | -40,611 |
Cash | 3,240 | 3,232 | 7,571 | 13,382 |
Basic Shares | 3,225 | 2,518 | 2,338 | 2,173 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.41 |
2025-12-31 | -$0.19 |
2025-09-30 | -$0.30 |
2025-06-30 | -$0.11 |